Purpose: To identify the differences in risk factors and visual field (VF) changes between juvenile primary open-angle glaucoma (JOAG) and late-onset chronic open-angle glaucoma (COAG). Methods: The demographic and presenting clinical data of 27 JOAG and 30 COAG patients were retrospectively reviewed. Comparisons between the two groups were performed using Mann-Whitney U test, Wilcoxon signed-rank test, and Fisher’s exact test. Results: A family history of glaucoma (37%) and a history of steroid usage (14.8%) were identified in JOAG patients only. The JOAG patients had a longer axial length (p < 0.001) and more often a myopic refractive state (p < 0.001) than the COAG patients. Patients with COAG showed a deeper (p = 0.016) and a more extensive (p = 0.008) defect in the superior than in the inferior hemifield, as well as a deeper (p = 0.016) and a more extensive (p = 0.001) defect in the superior than in the inferior arcuate area, while JOAG patients showed symmetric VF defects between the superior and inferior hemifields. Purely diffuse VF depression is more common in JOAG than in COAG patients (p = 0.03). Conclusions: JOAG patients demonstrated more axial myopic changes than patients with COAG as well as a pattern of superior-inferior symmetric VF defects. Axial myopia may play a critical role in the pathogenesis of JOAG.

Keywords:
Open-angle glaucoma, Age of onset, glaucoma, Risk factors, glaucoma, Visual field changes, Myopia
1.
Leske MC, Connell AMS, Wu SY, Hyman LG, Schachat AP, the Barbados Eye Study Group: Risk factors for open-angle glaucoma: The Barbados Eye Study. Arch Ophthalmol 1995;113:918–924.
2.
Klein BEK, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ: Prevalence of glaucoma: The Beaver Dam Eye Study. Ophthalmology 1992;99:1499–1504.
3.
Armaly MF, Krueger DE, Maunder L, Becker B, Hetherington J Jr, Kolker AE, Levene RZ, Maumenee AE, Pollack IP, Shaffer RN: Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol 1980;98:2163–2171.
4.
Safran MJ, Robin AL, Pollack IP: Argon laser trabeculoplasty in younger patients with primary open-angle glaucoma. Am J Ophthalmol 1984;97:292–295.
5.
Gressel MG, Heuer DK, Parrish RK II: Trabeculectomy in young patients. Ophthalmology 1984;91:1242–1246.
6.
Funkhouser AT, Fankhauser F, Weale RA: Problems related to diffuse versus localized loss in the perimetry of glaucomatous visual fields. Graefe’s Arch Clin Exp Ophthalmol 1992;230:243–247.
7.
Bebie H, Flammer J, Bebie T: The cumulative defect curve: Separation of local and diffuse components of visual field damage. Graefe’s Arch Clin Exp Ophthalmol 1989;227:9–12.
8.
Mitchell P, Hourihan F, Sandbach J, Wang JJ: The relationship between glaucoma and myopia: The Blue Mountains Eye Study. Ophthalmology 1999;106:2010–2015.
9.
Perkins ES, Phelps CD: Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction. Arch Ophthalmol 1982;100:1464–1467.
10.
Perkins ES: Glaucoma in the younger age groups. Arch Ophthalmol 1960;64:882–891.
11.
Lotufo D, Ritch R, Szmyd L, Burris JE: Juvenile glaucoma, race, and refraction. JAMA 1989;261:249–252.
12.
Lin LLK, Shih YF, Tsai CB, Chen CJ, Lee LA, Hung PT, Hou PK: Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci 1999;76:275–281.
13.
Goh WS, Lam CS: Changes in refractive trends and optical components of Hong Kong Chinese aged 19–39 years. Ophthalmic Physiol Opt 1994;14:378–382.
14.
Podos SM, Becker B, Morton WR: High myopia and primary open-angle glaucoma. Am J Ophthalmol 1966;62:1039–1043.
15.
Quigley HA: Reappraisal of the mechanisms of glaucomatous optic nerve damage. Eye 1987;1:318–322.
16.
Cahane M, Bartov E: Axial length and scleral thickness effect on susceptibility to glaucomatous damage: A theoretical model implementing Laplace’s law. Ophthalmic Res 1992;24:280–284.
17.
Hart WM, Becker B: The onset and evolution of glaucomatous visual field defects. Ophthalmology 1982;89:268–279.
18.
Drance SM: The early field defects in glaucoma. Invest Ophthalmol Vis Sci 1969;8:84–91.
19.
Dandona L, Quigley HA, Brown AE, Enger C: Quantitative regional structure of the normal human lamina cribrosa: A racial comparison. Arch Ophthalmol 1990;108:393–398.
20.
Chen YF, Wang TH, Lin LLK, Hung PT: Influence of axial length on visual field defects in primary open-angle glaucoma. J Formos Med Assoc 1997;96:968–971.
21.
Araie M, Arai M, Koseki N, Suzuki Y: Influence of myopic refraction on visual field defects in normal tension and primary open angle glaucoma. Jpn J Ophthalmol 1995;39:60–64.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.